FMP

FMP

Enter

BJDX - Bluejay Diagnostics,...

Financial Summary of Bluejay Diagnostics, Inc.(BJDX), Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, d

photo-url-https://financialmodelingprep.com/image-stock/BJDX.png

Bluejay Diagnostics, Inc.

BJDX

NASDAQ

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

0.579 USD

-0.0307 (-5.3%)

About

ceo

Mr. Indranil Dey

sector

Healthcare

industry

Medical - Devices

website

https://www.bluejaydx.com

exchange

NASDAQ

Description

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP ...

CIK

0001704287

ISIN

US0956333019

CUSIP

095633103

Address

360 Massachusetts Avenue

Phone

844 327 7078

Country

US

Employee

10

IPO Date

Nov 10, 2021

Summary

CIK

0001704287

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

095633103

ISIN

US0956333019

Country

US

Price

0.58

Beta

0.85

Volume Avg.

39.19k

Market Cap

1.56M

Shares

-

52-Week

0.47-13.98

DCF

1.68

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.06

P/B

-

Website

https://www.bluejaydx.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest BJDX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep